level-one heading

Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss requirements with the expert in detail before accepting statement of work from Kolabtree
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but approve the deliverables only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
★★★★★
☆☆☆☆☆
USD 50 /hr
Hire Dr. Erick S.
Netherlands
USD 50 /hr

M. D. With a PhD in Epidemiology

Profile Summary
Subject Matter Expertise
Services
Writing Medical Writing
Research Systematic Literature Review
Consulting Scientific and Technical Consulting
Data & AI Predictive Modeling, Statistical Analysis, Data Visualization, Data Cleaning
Work Experience

Postdoctoral Researcher

University Medical Center Groningen (UMCG)

May 2025 - Present

PhD candidate

University of Groningen

May 2021 - May 2025

Education

PhD

University of Groningen

May 2021 - May 2025

Medical Doctor (Medicine)

Consorcio Universidad Nacional Autonoma de Mexico

July 2014 - December 2020

Certifications
  • Certification details not provided.
Publications
JOURNAL ARTICLE
Erick Suazo-Zepeda, Alain R. Viddeleer, Willemijn J. Maas, Douwe Postmus, Marjolein A. Heuvelmans, T. Jeroen N. Hiltermann, Geertruida H. De Bock (2025). CT-assessed sarcopenia and immune-related adverse events in patients with lung cancer: A competing risk time-to-event analysis . Lung Cancer.
Sean P. McClellan, Karla Unger-Salda&#241;a, Priscilla Espinosa-Tamez, Erick Suazo-Zepeda, Michael B. Potter, Salim Abraham Barquet-Mu&#241;oz, Leticia Torres-Ibarra, Hector Lamadrid-Figueroa, Mart&#237;n Lajous (2023). The Cervical Cancer Treatment Gap in Mexico Under <i>Seguro Popular</i> , 2006-2016 . Health Systems &amp; Reform.
E. Suazo-Zepeda, P.C. Vinke, M.A. Heuvelmans, G. Sidorenkov, T.J.N. Hiltermann, G.H. de Bock (2023). Quality of life after treatment with immune checkpoint inhibitors for lung cancer; the impact of age . Lung Cancer.
Karla Unger-Salda&#241;a, Alejandra Contreras-Manzano, H&#233;ctor Lamadrid-Figueroa, Alejandro Mohar, Erick Suazo-Zepeda, Priscilla Espinosa-Tamez, Martin Lajous, Michael R. Reich (2022). Reduction in the Treatment Gap for Breast Cancer in Mexico under Seguro Popular, 2007 to 2016 . Health Systems & Reform.
E. Suazo-Zepeda and M. Bokern and P. C. Vinke and T. J. N. Hiltermann and G. H. de Bock and G. Sidorenkov(2021). Risk factors for adverse events induced by immune checkpoint inhibitors in patients with non-small-cell lung cancer: a systematic review and meta-analysis . Cancer Immunology, Immunotherapy. 70. (11). p. 3069--3080. Springer Science and Business Media {LLC}
Priscilla Espinosa-Tamez and Erick Suazo-Zepeda and Hugo S{\'{a}}nchez-Blas and M{\'{o}}nica Meneses-Medina and Fidel David Huitzil-Mel{\'{e}}ndez and Katherine Van Loon and Michael Potter and Mart{\'{\i}}n Lajous(2021). National and state-level colorectal cancer mortality trends in Mexico, 1998-2018 . Salud Pública de México. p. 1--9. Instituto Nacional de Salud Publica